A new hope for patients affected by Alzheimer’s disease CaSRevolution is a research company specialized in devising innovative therapies for neurodegeneration diseases We have discovered a new mechanism that explains the progression of Alzheimer’s Disease and identified a potential therapeutic approach biotech, neurodegeneration, startup, and alzheimer

115 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Unlocking human potential with breakthrough mammary biotechnology. BIOMILQ is a women-owned and science-led mammary biotechnology start-up leveraging its patented technology to produce functional cell-cultured human milk components outside the body. With the goal of bridging the gap between breast milk and infant formula, BIOMILQ aims to revolutionize early-life nutrition by bringing more of the benefits of breast milk to more babies. Femtech, Biotechnology, infant nutrition, Social Venture, and Female Founder

52 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

We're on a mission to cure blindness with our transformational platform of advanced therapies Aurion Biotech is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness. Our first candidate is for the treatment of corneal endothelial disease, and one of the first clinically validated cell therapies for corneal care.

71 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Bringing precision to the power of biologics with pioneering use of synthetic nanoclays for regenerative medicine. Renovos Biologics Ltd. (Renovos) is a biotech/medtech company focussed on the development of its patented synthetic nanoclay, RENOVITE®, as a drug delivery platform for regenerative medicine and beyond. Regenerative Medicine, Biomaterials, Drug Delivery, Medical Devices, Pharmaceuticals, Stem Cells, Orthopaedics, and Biotechnology

121 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Regain control with personalized muscle regeneration MUVON Therapeutics is a clinical stage Life Science spin-off from the University of Zurich developing a therapeutic platform for the regeneration of skeletal muscle tissue based on autologous cells, not only repairing damaged tissue but also increasing the regenerative potential of weakened muscles. Our initial area of focus is the treatment of stress urinary incontinence in women, supporting them respectfully throughout their journey to a healthy life.

55 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Developing novel multi-targeted antibiotics with extraordinary potency against multi-drug resistant bacteria. smartbax develops novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms. With the first-in-class compounds, the company targets the multi-drug resistant pathogens methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).

27 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

On-target gene therapies Alia Therapeutics is a pioneering gene editing company with a vision to revolutionize medicine by curing genetic diseases at their roots. Alia’s versatile portfolio of novel CRISPR systems expands the range of targetable genomic sites and increases the precision of genetic modifications, bringing gene editing to the next level of specificity and safety, which are required for therapeutic applications.

69 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

InvenireX is democratizing detection of nucleic acid biomarkers InvenireX is developing real-time, ultra-sensitive Nucleic Acid detection instrumentation powered by the latest object-detection neural networks, to empower our Scientists to accelerate life-sciences research.

89 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I.

Targeting synthetic lethality in cancer Eisbach Bio is an innovative start-up in biotechnology founded in 2019 as a spin-out of the Biomedical Center Munich. We are developing novel drugs that successfully target molecular vulnerabilities arising in cancer genomes. Eisbach will beat cancer at its own game.

61 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Synthetic DNA production for cutting-edge biotechnology solutions. NunaBio is a privately-owned specialist DNA synthesis and development company. We are engaged in CRO (Contract Research Organizations) and CDMO (Contract Development and Manufacturing Organisation) activities. The company has built a solid reputation for its R&D flexibility and innovative approach to complex and challenging projects. NunaBio’s core expertise is research and development into cell-free DNA synthesis, process optimisation, route design, scale-up and small-scale manufacture for clinical studies. DNA, Custom DNA, Gene Synthesis, Synthetic Biology, Biotechnology, and DNA Synthesis

59 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Curileum is intervening early in serious gastrointestinal (GI) disease development with novel diagnostics & therapeutics Curileum is intervening early in serious GI disease development with novel therapeutics to detect and correct cell production in the gut mucosa Biotechnology

153 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Treating cancer with γδ T cells | Nasdaq Ticker - $TCBP TC BioPharm is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease. We have a growing team based in our Glasgow office, alongside a wide range of scientific advisors, and partner organisations. Clinical Grade Cell Therapy, Cancer Immonotherapy, Regenerative Medicine, and Stratified Medicine

208 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Aiming to provide improved treatments for chronic respiratory diseases through new, innovative drug substances Aiming to provide improved treatments for chronic respiratory diseases through new, innovative and patent protected substances, thereby reducing suffering and ameliorating quality of life for patients.

380 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Unleashing biotech innovation for a greener and fairer future For those creating a more sustainable future with biotechnology, we use AI and computational modelling to help precision fermentation alt protein companies optimise their downstream processing, so they can de-risk their ventures, speed up R&D and reduce costs. Biotechnology, Bioprocessing, Biomanufacturing, Precision Fermetation, ClimateTech, Alternative Protein, Computational Modelling, and Downstream Processing

188 similar entities Type: Startup Activities: manufacturing biotech deeptech Technologies: Synthetic Biology

Unlocking the next generation of mRNA medicines. At Sensible Biotechnologies, we are building best-in-class platform for manufacturing of high-quality mRNA in a scalable way to unlock the next generation of mRNA medicines and strengthen the global biosecurity.

109 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Delivering therapies through targeted hyperoxygenation We are developing miniaturized hyperoxygenation therapies! The first application for our technology is miniaturized respiratory assist in patients suffering from lung failure.

60 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Light Activated Technologies for treating cancers and rare diseases Lightox has developed a new drug for the treatment of early stage oral cancers. The topically applied formulation allows for specific delivery to the lesion and is activated by a specific wavelength of light.

59 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Automation and standardization of cryopreservation processes for Cell Therapies Cellulis (formerly ZF Biotox) provides disruptive cryopreservation technologies in a broad range of biotechnology fields aiming to innovate CELL THERAPY solutions, to streamline BIOPROCESSING production, to enhance BIOBANKING and to improve High Throughput Screening (HTS) campaigns. Frozen Cells in Microplates Ready to Use., Final product formulation for cryopreserved cell therapy, and Cryopreservation of Cell Therapies

68 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Developing revolutionary biomaterials for regenerative medicine. Spiderwort Inc. is a tissue engineering company specializing in the development of transformative biomaterials for repairing and regenerating tissues within the human body.

60 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Developing a biobased future is our passion. Industrial biotechnology is our business. The BRAIN Biotech Group is a leading company in the research, development and production of specialty enzymes with a focus on the food and life science industries. In addition, the Group develops microbial production organisms and scalable bioprocesses for the economic production of specialty enzymes and other proteins. Customized innovative biological solutions for more sustainable products and processes round off the portfolio. The parent company of the BRAIN Biotech Group is BRAIN Biotech AG. The business activities of the integrated company are divided into the two segments BRAINBiocatalysts …

73 similar entities Type: SMB Activities: healthtech biotech civictech deeptech Technologies: Batteries Bio sourced materials Synthetic Biology

An early-stage oncology company aiming to treat solid tumors SOLID Therapeutics is an early-stage oncology company spun out of CBMR at the University of Copenhagen. We are developing novel cancer therapeutics with dual mode of action targeting both cancer cells and immune cells to treat solid tumors.

107 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Galactica Biotech provides a drug repurposing method to identify novel applications for molecules in the market and in development for major and orphan diseases, reducing risk for patients and time and cost for companies. Our Mission With our specialized knowledge we are targeting to set new standards in the pharmaceutical industry adding value to old drugs and contributing to the health of people. Drug Discovery, Molecule characterization, Drug repurposing, and Novel compound applications

290 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology

Pioneering CAR Macrophage Immunotherapy to Target Solid Tumors Carisma Therapeutics Inc. is a clinical stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response. Carisma is headquartered in Philadelphia, PA.

42 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Developing the Next Generation Gene Editing Technology Pencil Biosciences is developing a truly innovative gene modulation technology that can have an impact across a range of applications, including new therapeutic options for patients with rare diseases. Genome Engineering, Research and Development, and Gene Editing

299 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Building Better Biology At MarraBio we design, engineer and construct bacterial protein polymers, that contain the biological messages that cells need to grow, divide and behave properly. Cells grown on an industrial scale for research, agricultural or therapeutic use need to be supplied with the right signals. We provide a multi-functional, cost effective solution in a single, easy to use material. Find out more at https://www.marrabio.com/ Protein Engineering, Protein Production, Cellular Agriculture, Cultivated Meat, Research Reagents, Stem Cell Expansion, and Industrial Scale Cell Culture

138 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Changing the world, one sequence at a time. Synbio Technologies aims to become the most trusted provider of DNA solutions that empower scientific discoveries by providing highly-accurate and cost-effective synthetic biology services and products for researchers around the world. We have developed a full range of DNA reading (sequencing), DNA writing (synthesis), and DNA editing (engineering) capabilities for various applications, including diagnostic DNA probes, precision medicine, protein production, antibody discovery, vaccine development, novel enzymes, molecular breeding, biofuel implication, and more. Our scientific capabilities cover all facets of DNA synthesis and engineering, offering a full range of support for molecular biology …

76 similar entities Type: Startup Activities: manufacturing deeptech biotech Technologies: Synthetic Biology

Casting light on the microbiome We founded mbiomics to improve peoples lives by providing a novel approach to fully understand the secrets of the microbiome with the goal to better inform targeted therapies and how to lead a healthy life. microbiome, precision medicine, biotechnology, diagnostics, immuno-oncology, and companion diagnostics

72 similar entities Type: Startup Activities: deeptech biotech

Technology to ignite the biology revolution We are a Cambridge-based company developing a radically different approach to gene synthesis. Our desktop DNA synthesis platform will provide the ability to synthesise DNA at unprecedented accuracy, scale and speed, accelerating scientists'​ ability to use synthetic biology on a scale not currently possible. Biotechnology, Synthetic Biology, DNA synthesis, Gene synthesis, and synbio

165 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

The platform for creating organs and tissues in the lab. The platform for creating organs and tissues in the lab. Biotechnology, Biomaterials, Bioprinting, 3D Cell Culture, Tissue Engineering, Hydrogels, Regenerative Medicine, Research, and Tissue Culture

113 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

We developed and patented a #technology to obtain #food grade #proteins from #rapeseed (#canola) and other oilseeds. Beneficiary of #SMEInstrument #H2020 and the proud member of #RisingFoodStars #EITFood The NapiFeryn technology makes it possible to retrieve all protein contained in rapeseed, which makes the proposal unique worldwide. biotechnology, food industry, alternative proteins, rapeseed protein, and raptein

62 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Better Technology. Better Delivery. Developing a new generation of disease-modifying therapies. Driven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, we are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic neuromuscular and neurological disorders. Biotechnology, Chemistry, Biology, Bioscience, Life sciences, and Therapeutics

436 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Focused on the development of precisely targeted, controlled & highly active T cell therapies for cancer Autolus is a CAR T cell therapy company. We are applying our extensive programming capabilities to develop advanced autologous T cell therapies that have the potential to deliver life-changing therapies to patients with cancer and autoimmune diseases.

83 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Dedicated to Improving Life. Precision BioSciences, Inc. (Nasdaq: DTIL) is a clinical stage gene editing company developing in vivo gene editing with its highly precise and versatile ARCUS genome editing platform. ARCUS uses sequence-specific DNA-cutting enzymes, or nucleases designed for gene knock out, as well as highly complex edits for gene insertion and/or gene repair. Precision BioSciences is based in Durham, North Carolina. For more information about Precision BioSciences please visit www.precisionbiosciences.com. Gene Editing and Gene Therapy

59 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Developing deuterated BEST in CLASS MET kinase Inhibitor DeuterOncology NV is a Liege based clinical stage biotechnology company that was founded in September 2020 by Dr Timothy Perera. The company is currently focused on the clinical development of a highly selective brain penetrant, deuterated MET kinase inhibitor DO-2. Drug Development, Deuterated small molecules, and MET kinase inhibitor

68 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Delivering longer, better quality lives for brain tumour patients QV Bioelectronics is a VC-backed medical device startup developing an implantable electric field therapy treatment for aggressive brain tumours.

120 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Platform to engineer cancer killing viruses using synthetic biology. Humane Genomics is developing a platform to engineer cancer killing viruses with unprecedented specificity and efficiency. Our first indication is liver cancer. We are based in New York City and backed by amazing investors. (YC S21)

60 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Pioneering onsite upcycling of plant-based side-streams Carbiotix is an award-winning biotechnology company pioneering the onsite upcycling of plant-based side-streams. Carbiotix mission is to improve the health of people by increasing the consumption of prebiotics and other active ingredients from upcycled side-streams. Carbiotix offers one core service today called NutraCycle, an on-site upcycling and fortification service allowing food & beverage, ingredient, and feed producers to turn plant-based products into healthier, more profitable, and sustainable products. Gut Health, Microbiome, Prebiotics, Upcycling, Plant-based, Food & Beverage, Ingredient, Feed, Biotechnology, Process Engineering, Product Design, Active Ingredients, and Onsite

28 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Mastering the microbiome, transforming lives® EnteroBiotix is a leading microbiome therapeutics platform company that is focussed on transforming the standard of care for patients battling debilitating diseases and infections linked to disruptions to structure and function of the gut microbiome.

201 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Making Regenerative Medicine Accessible Roumai Medical is developing next-generation biotechnologies in regenerative medicine and human-machine interface to meet the unmet clinical needs of millions of patients worldwide.

398 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Novel Biologics. Designed by Evolution. Discovered by AI. Novel Biologics. Designed by Evolution. Discovered by AI. AMPLY Discovery uses machine learning and synthetic biology to mine vast biological data to discover novel biologic drug and nutraceutical candidates. Using a proprietary in silico and in vitro hybrid platform to discover best-in-class molecules AMPLY is helping tackle some of humankind's greatest challenges such as cancer, MDR infections and metabolic diseases. Based in Belfast, Northern Ireland. Spin out from Queen's University Belfast. Biotechnology, Anti-infectives, Drug Discovery, AI, Machine Learning, Animal Health, Healthcare, Genomics, Metagenomics, Cancer, Biologics, Metabolic Diseases, Natural Drugs, Nutraceuticals, and Bioinformatics

63 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology A.I. - Machine Learning

We believe that everyone - irrespective of who they are or where they live - deserve medications that work We believe that everyone - irrespective of who they are or where they live - deserve medications that work

215 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

CDMO Services (Research, Development and cGMP Manufacturing for Biologics) Bionova Scientific is a dynamic, full service, biologics Contract Development and Manufacturing Organization (CDMO) on a mission to deliver the highest quality process development and manufacturing services to biologic drug development companies around the world. Bionova’s renowned scientific expertise and dedication to its customers helps life changing therapies arrive to the market faster and more efficiently. At the heart of Bionova is a team of highly dedicated experts combining strong experience in cGMP biologics manufacturing and process development, with a technology-focused approach and a deep knowledge of the industry. From early …

34 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

We are now 3PBIOVIAN! Follow us on our new LinkedIn page, 3PBIOVIAN, to stay updated on all the latest developments and news! 3P Biopharmaceuticals and Biovian join forces to create 3PBIOVIAN, a leading pan-European biologics CDMO. Read more here: www.3pbiovian.com ***** 3PBIOVIAN is a globally operating Contract Development and Manufacturing Organization (CDMO), delivering end-to-end services for biotech and pharma companies. Our service offering includes microbial and mammalian protein expression platforms, viral vector production for adenoviruses and adeno-associated viruses, cell therapy, and plasmid DNA production. Additionally, we provide fill and finish services for recombinant proteins and viral vectors. With a combined …

77 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Nanovery - experts in nucleic acid quantification using nanorobots. We have created a proprietary Nucleic Acid Nanorobotics (NANs) platform that simplifies molecular testing and quantification for RNA therapeutics and biomarkers.

63 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Precision Drugs against Eucaryotic Pathogens ASTRA Therapeutics is a Drug Discovery company with a mission to design and develop novel, precision engineered drugs against a whole range of Eukaryotic Pathogens.

505 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

A startup using Synthetic Biology to innovate the way we develop entirely novel classes of protein-based drugs. Our patent-pending biotech platform, Phactory, makes designing synthetic proteins 10,000x more effiicent and reduces the material costs by 100x. We are leveraging Phactory to develop the newest classes of protein-based drugs, such as the next generation of antibiotics.

126 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Enabling Proteins for a Better Tomorrow Protevo Bio enables proteins for a better tomorrow. By solving the bottlenecks of conventional production processes, we make bioactive proteins available at large scales and low cost for cost-sensitive industrial applications.

74 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Exploiting a new class of tumour specific antigens for cancer therapy A newly established NewCo developing therapeutics targeting a novel class of tumour-specific antigen. TCR-T cells, Immuno-oncology, Vaccines, Bi-specifics, Splicing, Epigenetics, Oncology, T cell biology, and Antigen presentation

170 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Decoding cardiovascular disease biology for novel therapeutic discovery CardiaTec is a TechBio company employing computational methods to decode the biology behind cardiovascular disease. We leverage large and high-dimensional human omics data to better navigate complex disease biology to discover novel and differentiated therapeutics.

88 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Sino Biological, headquartered in Beijing, China, is a global leader in recombinant protein and antibody production, gene synthesis, and CRO services for life sciences research and drug development. Its facilities include the Center for Bioprocessing (C4B) in Houston, Texas, which specializes in mammalian cell-based protein and antibody production, and SignalChem Biotech (SCB) in Vancouver, Canada, focusing on kinase-related reagents, stable cell line development, and therapeutic discovery. With a U.S. office providing localized support, Sino Biological ensures innovative, high-quality solutions for global academic and industrial clients. Recombinant Protein , Elite Antibody , ELISA kits, Gene/cDNA, CRO Service, Biotechnology tools and solutions, …

77 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Outsmarting complex diseases with more intelligent medicines Our mission is to create a new generation of smarter medicines that outmaneuver complex diseases in ways previously inconceivable. To accomplish this mission, we are building a synthetic biology platform that could enable us to program next-generation cell and gene therapies with what we refer to as “gene circuits”. These gene circuits, which are created from novel and proprietary combinations of DNA sequences, are intended to reprogram cells with biological logic to sense inputs, compute decisions and respond to their cellular environments. We are designing gene circuits to improve the “intelligence” of cell …

82 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Expert-Led Life Sciences Training and Certifications for Non-Scientists to Advance Your Career Biotech Primer’s mission is to provide high-quality educational resources to professionals in the life sciences sector, focusing on the unique needs of non-scientists. With over 150,000 professionals trained since its founding in 2001, we offer a wide range of specialized courses that cover essential topics such as drug development, biotech business strategies, medical device development, and biotech manufacturing processes. Our programs are designed to make complex scientific concepts accessible, empowering professionals to understand the intricacies of the life sciences industry and excel in their roles. Biotech Primer’s courses …

57 similar entities Type: NGO, Think-tanks, Ed, & Culture SMB Activities: edtech Technologies: Synthetic Biology

Reinventing Chemistry for Life Sciences The leading innovator and manufacturer of photoreactors, metabolites and LEDs since 2008 Metabolite synthesis, photochemistry, research instrument, and photoreactor

88 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Develop human organ models with true physiological complexity We are specialized in the production and development of human, immunocompetent Organ-on-Chip technology for in vitro disease and infection modelling. Organ-on-Chip, Human Cell Biology, Infection, Infectious disease, Toxicity profiling, Immune Cell Interactions, Inflammatory Diseases, Antibody recycling, and Uptake / Transport studies

128 similar entities Type: Startup Activities: manufacturing biotech deeptech Technologies: Synthetic Biology

Biotal is a biotechnology company that is looking for, develops and values ​​innovative marine biomolecules. The unique expertise and know-how of biiotal allow the identification, characterization and marketing of molecules with very high potential for various sectors such as cosmetics, pharmaceutics or neutraceutics. Blue biotechnology, microbiology, biodiversity, and production of polymers

78 similar entities Type: Startup Activities: biotech deeptech manufacturing

Make with Biology Amino Labs' mission is to make biotechnology learning and innovation accessible to teenagers, educators, and adults. Youtube: https://www.youtube.com/c/AminoLabs Education, Genetic Engineering, STEM, Hands-on Experiments, Zero to Genetic Engineering Hero, biology kits, STEAM, and science education

71 similar entities Type: Startup Activities: deeptech industry 4.0 Technologies: Synthetic Biology

Advancing precision oncology therapeutics designed to deploy multi-faceted inhibition to reverse cancer resistance AUM Biosciences is focused on advancing a clinical pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance biotech, oncology, drug development, Asian-biotech, Precision medicine, Digitalhealth, cancer, and small molecules

550 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Liberating scientists & scaling cell biology Today, biologists spend too much time performing tedious manual tasks. Biologists should spend time on what they're exceptional at: pushing the frontiers of science and creating new medicines and products.‍ We build intelligent machines that decouple biology from manual labor. This accelerates research and provides clear paths to scaling innovations from the lab bench to the factory floor.

72 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Transforming crop protection We are an agricultural technology (agtech) company developing a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Based on our ground-breaking technology platform, Biotalys is developing a broad pipeline of crop protection products with novel modes of action, addressing key crop pests and diseases across the whole value chain, from soil to plate. Biotalys’ unique protein-based biocontrols aim to combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. We are on track to have …

59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Genewity is a pioneering biotech start-up focused on advanced thymus-driven therapies for immune reconstitution. Supported by the extensive business expertise of our management and advisors, we are at the forefront of developing and commercialising breakthrough therapies. With over 150 years of combined experience in immunology and gene therapy, our team is uniquely positioned to drive advancements in the field.

275 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

StemTek Therapeutics is a start-up biotechnolgy company dedicated to accelerating drug discovery in cancer using cutting edge technology, world-class science and a stem cell centric point of view for cancer therapy. Our mission is to help design novel treatments for cancer targeting cancer stem cells.

133 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Working at the frontier of microfluidics, automation and machine learning to accelerate cell-based medicines. Scaled Biolabs accelerates the discovery and development of complex cell-based medicines, such as stem cell therapies and cancer immunotherapies. Their full stack optimization engine reduces complexity and time to market, by leveraging high-throughput, micro-scale cell culture, automation, and deep data insight. It also powers internal, grant funded programs such as developing a new gold standard for manufacturing dopaminergic neurons to treat Parkinson’s disease. Microfluidics, Biomedical R&D, Bioreactor, Single-cell Biology, Bioengineering, Stem Cells, Tissue Engineering, Cell Culture, Cell-based Assays, machine learning, and computer vision

88 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. - Image Processing A.I. Synthetic Biology A.I. - Machine Learning

A life science company developing innovative technologies to enhance the health and beauty of your skin Fount Bio is applying proprietary advances in glycopolymer research to become the world’s first platform for building a long-lasting hyaluronic acid network within the skin via topical application. Fount’s Flī-HATM technology overcomes both the delivery and biostability challenges of current forms of HA, that until now, have prevented the development of products that fully unleash HA’s benefits without the need for invasive injections.

35 similar entities Type: Startup Activities: deeptech biotech Technologies: Bio sourced materials

The Digital Therapeutic Company in Urology Devicare is a specialty biotech company dedicated to develop pathbreaking medical treatments in Urology combining the most recent scientific advances in nutritional therapy with digital technologies. Biotechnology, Medical devices , Digital Health , eHealth, Healthcare, and Digital Therapeutics

383 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Drugging disordered proteins with physics and AI Peptone is a therapeutics company that uses AI and an experimental physics product engine to design small molecules targeting the 6,200 intrinsically disordered human proteins that Alpha Fold 3 cannot model. artificial intelligence, structural biology, high performance computing, supercomputers, biotechnology, and intrinsically disordered proteins

142 similar entities Type: Startup Activities: biotech deeptech it services Technologies: Synthetic Biology

we develop for patients Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, we conduct clinical development and then select large pharmaceutical commercialization partners for out-licensing to maximize patient access across the globe. Through this specialized business model, Debiopharm can focus on the development of prescription drugs that target unmet medical needs in oncology and bacterial infections. Debiopharm completed the development and has licensed out 2 compounds: - Triptorelin, the active substance of Decapeptyl®/Trelstar®/Pamorelin®/Triptodur® 1, 3 and 6-month formulation and Moapar®/Salcacyl® -Oxaliplatin, the active substance of the branded Eloxatin®/Elplat®/Dacotin®/Dacplat® If your university …

79 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Integrated Drug Discovery | Drug Development | Contract Research Selvita is one of the largest preclinical contract research organizations in Europe, driven by a clear mission: to offer a comprehensive scope of services bridging the gap between early drug discovery and the clinical stage of drug development. biotechnology, pharmaceuticals, drug discovery, preclinical research, bioanalytical development services, bioinformatics, systems biology, proteins, genomics, proteomics, autoimmune disorders, regulatory studies, medicinal chemistry, agrochemical, industrial chemistry, and assay development&screening

504 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Transforming Point of Need Multiplex Diagnostics QuantuMDx is a progressive MedTech company passionate about creating multiplex molecular diagnostic solutions for use at the point of need. MedTech, Molecular Diagnostics, Multiplex Molecular Diagnostics, Point of Care, Point of Need, COVID-19, Medical device, Diagnostic device, DNA extraction, TB, Sepsis, Transcriptomics, PCR, Microarray, Assay Development, Assay Feasibility, Rapid Diagnostics, Respiratory Infections, Sexually Transmitted Infections, Host Response, and In vitro Diagnostics

154 similar entities Type: Startup Activities: deeptech biotech healthtech nanotech Technologies: Synthetic Biology

Bio-Gene is an Australian agtech company enabling the next generation of novel insecticides. Follow our journey. Bio-Gene is an Australian AgTech company that produces a range of patent-protected platforms, QCIDETM and FlavocideTM, targeted at the insecticides market. These technologies have a novel mode of action that offer a new range of effective insecticides that are safe for consumers.

38 similar entities Type: Startup Activities: deeptech biotech Technologies: SaaS

Discovering from Green - Scientific research aimed at obtaining plants with better productivity, fruit quality or with high -value added properties (of interest to the consumer, farmers and the agri -food industry) and more stress resistant, as well as less dependent on chemical treatments, in order to contribute to less aggressive agriculture with the environment. - Advanced genomics, proteomic, metabolomic, bioinformatics, microscopy, quantification of plant hormones, DNA sequencing and gene expression analysis. - Training of research personnel. Biotechnology, Molecular Biology, Genomic, Proteomic, Bioinformatics, Metabolomics, Systems Biology, and Synthetic Biology

251 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

A Member of the Roche Group Poseida was acquired by Roche in early 2025 and is now part of the Roche Group. Poseida is a clinical-stage biopharmaceutical company advancing differentiated allogeneic cell therapies and genetic medicines with the capacity to cure. The Company's approach is based on its proprietary genetic editing platforms, including its non-viral DNA Delivery System, Cas-CLOVERTM Site-Specific Gene Editing System, Booster Molecule and nanoparticle gene delivery technologies, as well as in-house GMP cell therapy manufacturing. Genome Engineering, CAR-T cells, Gene Therapy, Gene Editing, Cell Therapy, Adoptive Cell Therapy, Multiple Myeloma, Prostate Cancer, Transposon, Non-viral, Biotechnology, Immunotherapy, Regenerative …

77 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

coIMMUNE is a privately held, clinical stage immune-oncology company that will redefine cancer treatment using best-in-class cellular immunotherapies. Our allogeneic CAR-CIK technology platform for liquid and solid tumors is a novel CAR therapy that promises enhanced efficacy with greatly reduced toxicity.

108 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

in vivo testing at the in vitro scale At Nagi Bioscience, we develop cutting-edge biological testing solutions enabling scientists to generate the insights they need to fuel life-changing discoveries in a faster, more efficient, and ethical way. Our pioneering Organism-on-Chip platform, SydLabTM One, seamlessly integrates into existing lab environments, enabling scientists to enhance efficiency, accuracy, and reproducibility like never before. By combining this innovative technology with our team’s expertise, we deliver customer-focused solutions that empower scientists to advance research and drive scientific thinking forward. #inwormwetrust Microfluidic technology, Drug Screening, Pre-clinical studies, Lab Automation Technology, Safety and Efficacy, Toxicology, AI, C. …

184 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

For humanity to thrive, we need transformative thinking in how vaccines and therapeutics are designed and produced. At Univercells, we believe in the power of small adaptations to drive big change. We embrace the spirit of evolution in everything we do. We are biotech innovators. We are scientists and entrepreneurs creating transformative platforms for the pharmaceutical and biotech industry, through technology, bioprocess know-how and entrepreneurial spirit. Biotechnology, mRNA, CDMO, and Services

88 similar entities Type: Startup Activities: manufacturing deeptech biotech Technologies: Synthetic Biology

Powering the next wave of genetic medicines through superior delivery ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation, genetic medicines technology that enables precise delivery to target organs and cells beyond the liver. RNA Therapies, Genetic Medicines, Non-Viral Lipid Nanoparticles, Genetic Respiratory Disease, Cystic Fibrosis, Primary Ciliary Dyskinesia, and Biotechnology

88 similar entities Type: Startup Activities: deeptech biotech nanotech Technologies: Synthetic Biology

Defy Limits. Deliver Results. Made Scientific is a leading cell therapy contract development and manufacturing organization (CDMO) dedicated to advancing the field of cell therapy. Since 2019, the company has specialized in developing, manufacturing, and releasing autologous and allogeneic cell therapy products for early- to mid-stage clinical trials, and has evolved into an end-to-end clinical-to-commercial service provider. Operating from two U.S.-based manufacturing facilities, Made Scientific combines the flexibility and entrepreneurial spirit of a specialist CDMO with the global expertise and resources of GC Corporation of South Korea, a global leader in the pharmaceutical and biotechnology sectors. CDMO, Process Development, Analytical …

88 similar entities Type: Startup Activities: manufacturing biotech deeptech Technologies: Synthetic Biology

TriSalus Life Sciences® seeks to transform outcomes for patients with solid tumors TriSalus Life Sciences is an oncology company integrating novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors.

138 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Forging a radically new commercial path for scientific discoveries. We license intellectual property from institutions and convert it into products that we manufacture in the Pigtown neighborhood of Baltimore Converting Science into Business, Entrepreneurship, Research, drug design, machine vision, custom materials, and aquaculture technologies

85 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Sealing The Broken Barrier Currently we are not hiring. Please beware of scammers Artus is a pre-clinical stage company developing first-in-class therapeutics for inflammatory and metabolic diseases by targeting barrier dysfunction.

59 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Better Access. Better Lives. Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars. Biopharmaceuticals, Research and Development, Biosimilars, Biotechnology, Pharmaceutical, Biogenerics, Health, Cell Line Development, Business Development, and Regulatory

232 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

A leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies BioLife Solutions is a leading supplier of class-defining cell and gene therapy bioproduction tools and services. Our tools portfolio includes our proprietary CryoStor® and HypoThermosol® biopreservation media for shipping and storage, the ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system and Sexton Biotechnologies cell processing tools. For more information, please visit www.biolifesolutions.com and follow BioLife on LinkedIn and X. We are a publicly traded company listed on the NASDAQ under the ticker symbol BLFS. Biopreservation Media for Cells, Tissues, and …

74 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

BioProcess InternationalTM is a monthly, controlled-circulation magazine devoted to the development, scale-up, and manufacture of biotherapeutics and biodiagnostics. Each issue provides the global industrial biotherapeutic community with up-to-date, peer-reviewed information detailing the business, politics, ethics, applications, products, and services required to successfully drive biopharmaceuticals, vaccines, and biodiagnostics through the development and manufacturing process. BPI is a business unit of Informa Connect https://informaconnect.com marketing, Biopharmaceutical, biotechnology, print, electronic, online, advertising programs, bioprocessing, vaccines, monoclonal antibodies, protein therapeutics, cell therapies, gene therapy, cell therapy, and biomanufacturing

181 similar entities Type: SMB Activities: biotech deeptech martech Technologies: Synthetic Biology

#Biotech company offering #proteomics detection tools since 2001. #Research news, promos, & blogs. #Biomarkers #CRO RayBiotech is a leading life sciences company providing proteomic discovery tools to scientists in 85 countries worldwide. RayBiotech is committed to accelerating research through innovation, leadership, and excellent products and service. Protein Immunoassays, ELISA Kits, Antibody Arrays, Glycoscience, Protein Arrays, Immunological Assays, Antibody Development, Assay Development, Custom Protein Expression, Statistical Analysis, CRO Services, Flow cytometry, Recombinant proteins, Aptamers, Phosphorylation, Biostatistics, and Bioinformatics

66 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

We develop breakthrough medicines for patients through precision small molecule design. Nimbus Therapeutics is a clinical-stage, structure-based drug discovery company developing novel small molecule medicines designed to act against well-validated but difficult-to-drug targets implicated in multiple human diseases. The company advances promising research based on a unique strategy that combines leading-edge computational technologies with a tailored array of machine learning-based predictive modeling approaches. Nimbus' pipeline includes a clinical-stage HPK1 inhibitor for the treatment of cancer (NCT05128487), as well as a diverse portfolio of preclinical programs focused on cancer, including a WRN program for MSI-H cancers, autoimmune conditions, and metabolic diseases. …

60 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Engineering better microbes for agriculture. Now a part of Ginkgo Bioworks. Joyn Bio is now a part of Ginkgo Bioworks! Learn more at https://www.ginkgobioworks.com/2022/10/18/ag-biologics-division-bayer-joyn/.

Type: Startup Activities: biotech deeptech Technologies: A.I.

An innovative gene editing company discovering and developing curative treatments for genetic diseases Bayer and CRISPR Therapeutics have entered into an agreement to create Casebia to discover, develop and commercialize new breakthrough therapeutics to cure blood disorders, blindness, and congenital heart disease. CRISPR Therapeutics will contribute its proprietary CRISPR-Cas9 gene-editing technology and intellectual property, while Bayer will make available its protein engineering expertise and relevant disease know-how. It is the first long-term strategic partnership of its kind to make a substantial investment in the development of target delivery systems in an effort to bring systemic in vivo CRISPR-Cas9 gene editing …

82 similar entities Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology

Clinical-stage biotech company transforming how disease is treated through targeted protein degradation science C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO® platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. C4T’s degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve …

61 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Developing a new class of ADCs based on NMT inhibition to treat cancer We are a UK biotech company focused on the discovery and development of a completely novel class of selective cytotoxic payloads for antibody drug conjugates (ADCs), based on inhibitors of N-myristoyltransferases (NMT) for the treatment of cancer.

226 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

UNITY is harnessing pathways of aging biology to develop new medicines, with a focus on retinal diseases. As pioneers in cellular senescence, UNITY is advancing the first senolytic therapeutic candidate for retinal diseases that aims to restore diseased tissue to a healthier state, a potentially paradigm shifting treatment in ophthalmology.

60 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Developing RNA's technologies Development of RNA-based technologies to enhance the productivity of crops (mainly intensive) which are respectful towards the environment and human health. Our OGM-free technology allows us to immunize crops against specific pathogens (fungi, insects, viruses), as a sort of "vaccine". In addition, we know how to modulate crop development, its response to the environment or the accumulation of metabolites of interest by designing RNAs as exogenous bioactive molecules to modulate the activity of plant genes. Fruits, Biotech, RNA, ARN, Plants, Vegetables, and Crops

65 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Ranomics offers innovative solutions for protein engineering, drug discovery, genomics research and synthetic biology Ranomics offers high throughput solutions for protein engineering, drug discovery, genomics research and synthetic biology. Using our VariantFind and VERG genomics platforms, Ranomics offers partners the a scalable solution to engineer and screen genetic variants in a wide range of model organisms. Our industry leading DNA Variant libraries and high-throughput cell assays help researchers to hit their research objectives faster and with better results than traditional methods. Over the years, we have worked with top biotech and pharma companies in the US and worldwide. Our partners …

186 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Plasticell is a biotechnology company that develops novel therapies through precise manipulation of stem cells and more differentiated cell types using award-winning combinatorial screening technology. Technolgy Innovate cell-based combinatorial screening technology allows us to develop optimised protocols for cell expansion, cell differentiation, gene transduction, biomolecule production as well as the provision of human cells for use in drug discovery. Pipeline Out therapeutic projects include advanced cell and gene therapies as well as drugs discovered by screening rare human cell types derived from stem cells Visit our website www.plasticell.co.uk for more details. Stem Cell Research, Biotechnology, and High Throughput Stemcell Research

102 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Humanigen, Inc. (HGEN) is a clinical-stage biopharmaceutical company seeking to transform the treatment of cancers and infectious diseases, including COVID-19, by preventing and treating cytokine storm via its novel, cutting-edge anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody neutralization and gene-knockout platforms. Its proprietary Humaneered® monoclonal antibodies, designed to optimize antibody properties, show promise in prevention/treatment of cytokine storm induced by SARS-CoV-2 (COVID-19), chimeric antigen receptor T-cell (CAR-T) therapy and graft versus host disease (GvHD) by neutralizing GM-CSF which is up-regulated in these conditions.

63 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Developing technologies for the biopharma industry to allow them to treat the root causes of diseases and disorders. Based in Lausanne, Switzerland, NewBiologix SA is a technology innovation company developing a proprietary and breakthrough DNA integration platform for the advanced engineering of human and mammalian cell lines for the improved production of viral vectors used in gene therapies. gene therapy, cell therapy, next-generation sequencing, NGS, rAAV, viral vectors, biologics, stable cell lines, Genomic Integration, stem cell, bioinformatics, capsid optimization, HEK293, gene expression, ATMPs, genomic, epigenetic, transcriptomic, mammalian cell lines, and human cell lines

288 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

As one of core operating companies of the Sumitomo Corporation Group, we contribute to enriching lives and the world through the improvement of the health and well-being by linking pharmaceutical companies in Japan and overseas, leveraging its global network and expertise.

160 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology New Materials

KernalBio creates mRNA therapies that instruct specific cells on how to make their own medicine Kernal creates mRNA therapies to cure severe diseases including cancer. Our mRNA therapies instruct specific cells on how to make their own drugs. With roots at MIT, Harvard and Big Pharma, our team previously built a successful Biotech company and has deep expertise in mRNA space. synthetic biology, RNA design, immunotherapy, covid-19, cancer, and mRNA therapy

108 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Rational design of new molecules and medicines, enabled by the fusion of artificial intelligence and structural biology. Atomic AI is a well-funded, early-stage biotech company transforming the rational design of molecules and medicines through the cutting-edge fusion of artificial intelligence and structural biology. Atomic’s unique R&D platform, based on research featured on the cover of Science (doi.org/10.1126/science.abe5650), provides new strategies to treat or cure previously-undruggable diseases by targeting RNA structure. We are an interdisciplinary team working across computational and experimental biology and believe that our strongest asset is our people. We're hiring! https://boards.greenhouse.io/atomai

22 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology Generative A.I.

Biology Simulated Founded in 2017, Redesign Science is a platform biotech working at the interface of physics-based molecular simulation and deep learning to create generative AI for drug discovery. We deploy our platform technology to develop first-in-class Protein Interaction Modulators against validated targets known to drive progression of multiple oncogenic and inflammatory diseases.

62 similar entities Type: Startup Activities: biotech deeptech Technologies: Generative A.I. A.I. Synthetic Biology A.I. - Deep Learning

Beyond Known Biology: The world's largest foundational biodiversity database for training AI Basecamp Research is an AI company dedicated to solving the most pressing challenges in the life sciences by exploring beyond known biology. The company discovers and designs proteins with artificial intelligence trained on its proprietary knowledge graph of nature, the largest and most diverse of its kind, to design biological solutions for pharma, food and industrial applications. Understanding the full genetic, evolutionary, and environmental context of each protein allows Basecamp Research to design tailored proteins for specific applications without the need for expensive and time-consuming directed evolution campaigns. …

73 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology SaaS A.I.

Berkeley Lights is now part of Bruker Cellular Analysis Berkeley Lights is now part of Bruker Cellular Analysis biotech, single cell, micro-fluidics, cancer genomics, human oncology, life science, optics, molecular biology, and oncology

130 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology